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Abstract: Our study aimed to examine the status of plasma fatty acids (FAs), inflammatory markers, and lipid peroxidation in
patients with femoral neck fractures. The study included 20 patients (64–86 years) with femoral neck fractures indicated for
surgery and a control group of 17 elderly subjects without fractures or serious chronic diseases. Plasma was obtained during the
first 12 h postfracture and presurgery and 7 days postop. Compared to the control, patients had significantly higher saturated FA
(SFA) and monounsaturated FA as well as increased TNF- and IL-6. Opposite to that, levels of individual and total n-6 polyun-
saturated FA (PUFA), individual and total n-3 PUFA, n-6/n-3 ratio, and levels of thiobarbituric acid reactive substances (TBARS)
were markedly lower in the patient than in the controls. On the seventh day after the surgery, we showed a further rise in the
SFA, oleic acid, and TNF- and reductions of n-6 PUFA and IL-6. Taken together, our results suggest that altered FA status,
especially reduced PUFA, may influence hip fracture repair and even contribute to femoral fracture susceptibility in the elderly.
A potential benefit from nutritional intervention with PUFA in prevention and (or) fracture healing should be considered.
Key words: femoral neck fracture, presurgery, postsurgery, fatty acid, arachidonic acid, TNF-, IL-6, thiobarbituric acid reactive
substances.
Résumé : Nos travaux visaient à étudier l’état des acides gras, marqueurs de l’inflammation et de la peroxydation lipidique, chez
des patients présentant une fracture du col du fémur. L’étude portait sur 20 patients (de 64 à 86 ans) présentant une fracture du
col du fémur avec indication d’intervention chirurgicale et un groupe témoin de 17 sujets âgés sans fracture ni maladie
chronique grave. Nous avons obtenu du plasma dans les 12 premières heures suivant la fracture et avant l’intervention chirur-
gicale, ainsi que 7 jours après celle-ci. Les patients présentaient des taux nettement plus élevés d’acides gras saturés et mono-
insaturés, ainsi que de facteur de nécrose tumorale  (TNF-) et d’interleukine 6 (IL-6) que les témoins. À l’opposé, les taux
d’acides gras n-6 individuels et polyinsaturés totaux, d’acides gras n-3 individuels et polyinsaturés totaux, le ratio n-6/n-3 et les
taux de substances réagissant à l’acide thiobarbiturique (TBARS pour « thiobarbituric acid reactive substances ») étaient nette-
ment moins élevés chez les patients que chez les témoins. Au 7e jour après l’intervention chirurgicale, nous avons montré une
augmentation supplémentaire des taux d’acides gras saturés, d’acide oléique et de TNF-, avec des diminutions en matière
d’acides gras polyinsaturés n-6 et d’IL-6. Dans l’ensemble, nos résultats laissent entendre que les modifications sur le plan des
acides gras, en particulier l’abaissement des acides gras polyinsaturés, pourraient influencer la réparation de la fracture de la
hanche et même contribuer à la susceptibilité aux fractures fémorales chez les personnes âgées. On devrait prendre en compte
les bienfaits éventuels d’interventions de nature alimentaire sur les acides gras polyinsaturés dans la prévention ou la guérison
des fractures. [Traduit par la Rédaction]
Mots-clés : fracture du col du fémur, avant l’intervention chirurgicale, après l’intervention chirurgicale, acide gras, acide
arachidonique, TNF-, IL-6, substances réagissant à l’acide thiobarbiturique.
Introduction
Femoral neck fractures as a common source of morbidity and
mortality, especially in the elderly, represent a global health chal-
lenge. Treatment of injuries is complex and usually requires sur-
gery (Ossendorf et al. 2010). Femoral fractures can be caused by an
injury and (or) low bone density, with women with osteoporosis
being in the highest risk (Kopperdahl et al. 2014). Other risk fac-
tors are smoking, high low-density lipoprotein levels, increased
homocysteine, and fat mass (Martínez-Ramírez et al. 2007).
Many human, animal, and in vitro studies have led to better
understanding of biochemical processes during the fracture heal-
ing (Einhorn 2005). Generally, bone healing goes through four
stages: inflammation, soft callus formation, hard callus forma-
tion, and remodeling (Marsell and Einhorn 2011). Recently, the
potential roles of polyunsaturated fatty acids (PUFA) in inflamma-
tory regulation of bone remodeling, including gene transcription,
have been highlighted. Arachidonic acid (AA) (C20:4 n-6) increases
expression of peroxisome proliferator activator receptor gamma
Received 30 April 2019. Accepted 2 August 2019.
A. Arsic, S. Petrovic, and V. Vucic. Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade,
Belgrade, Serbia.
G. Pesic. Orthopedic and Traumatology Clinic, Podgorica, Montenegro.
A. Matic. Clinic of Orthopedic Surgery, Clinical Centre of Kragujevac, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
J. Jeremic. Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
V. Jakovljevic. Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Corresponding author: Aleksandra Arsic (email: aleksandraarsicimi@gmail.com).
1This paper is part of a Special Issue entitled “Current trends in physiological sciences: from cell signals to the biology of aging”.
Copyright remains with the author(s) or their institution(s). Permission for reuse (free in most cases) can be obtained from RightsLink.
61
























































(PPAR), a transcription factor that inhibits the osteoblast prolif-
eration (Maurin et al. 2005). Due to high binding affinity, docosa-
hexaenoic acid (DHA) (22:6 n-3) reduces PPAR expression and
favors osteoblastogenesis (Mangano et al. 2013). Furthermore, AA
increases gene expression of several proinflammatory cytokines,
including interleukines (IL) IL-1 and IL-1, transforming nuclear
factor  (TNF-), and macrophage colony stimulating factor in
human osteoblast-like cells in vitro (Priante et al. 2002). During
the early inflammatory phase of fracture healing, a short, highly
regulated secretion of TNF, IL-1, IL-6, IL-11, and IL-18 has been
detected (Marsell and Einhorn 2011). This early inflammatory re-
sponse reaches its maximum after 24 h and ends after 7 days. IL-1
is believed to promote the primary cartilage growth, angiogene-
sis, and production of IL-6 in osteoblasts (Marsell and Einhorn
2011). IL-6 stimulates angiogenesis, vascular endothelial growth
factor production, and the differentiation of osteoblasts and oste-
oclasts (Yang et al. 2007).
Furthermore, AA can be metabolized by cyclooxygenase to pros-
taglandin E2, an important factor in bone resorption, genesis
of osteoblasts, and new bone production (Keila et al. 2001). AA
is synthesized from linoleic acid (LA) (18:2 n–6) via elongase
and desaturase activity (Ristic-Medic et al. 2013). Since LA and
-linolenic acid (ALA) (18:3 n–3) are essential FA that cannot be
synthesized by human tissues (Salari et al. 2008), studies suggest
that FA intake and status may be related to bone health (Farina
et al. 2012). It has been shown that saturated FA (SFA) intake may
significantly increase hip fracture risk, whereas monounsatu-
rated (MUFA) and PUFA, particularly n-3 PUFA, intake may de-
crease total fracture risk (Orchard et al. 2010; Chen et al. 2017). In
addition, serum levels of n-3 PUFA were positively correlated with
bone mineralization in mice and humans, while the deficiency of
essential FA may be associated with pathological fractures in rats
(Kruger et al. 2010). Considering the potential effects of PUFA on
bone metabolism and fracture healing, we hypothesized that low
PUFA status, particularly of n-3 PUFA, in patients is related to
appearance of femoral neck fracture. Secondary hypotheses were
that PUFA status during early fracture healing would improve as
compared to the preoperative status and that better PUFA status
would be associated with lower markers of inflammation. The
aim of this study was to determine the level of plasma FA, TNF-,
IL-6, and lipid peroxidation in elderly patients with femoral neck
fractures during the early stages of healing, i.e., within 12 h after
the fracture and on the seventh postoperative day.
Materials and methods
This study included 20 patients aged 64–86 years with femoral
neck fractures and indicated for surgery. Patients were recruited
from Orthopedic Clinic, Clinical Centre Kragujevac, during 2015.
Exclusion criteria were age below 64 years, serious liver, kidney,
or heart diseases, malignant diseases, use of statins, use of fish oil
or other supplements that influence FA metabolism, and unsuit-
ability for prosthesis. None of the patients had damage to the
spinal cord or peripheral nerve injury (quadriplegia, paraplegia,
hemiplegia). The study protocols were approved by the Ethical
Committee of the Clinical Centre of Kragujevac in accordance
with the Declaration of Helsinki and principles of Good Clinical
Practice. All subjects gave written participation consent. Given
that all patients were older than 64 years (average 73.4), trophic
changes in bone density could be classified as primary osteoporo-
sis due to age. The control group were 17 subjects without frac-
tures or serious chronic diseases and comparable in age and sex.
Measurements and laboratory data
Blood samples were taken within 12 h after the fracture and on
the seventh day after the operative reposition of the fracture. The
FA profile in plasma total lipids was isolated by the method of
Glaser et al. 2010 with some modifications. Individual FA were
determined by gas chromatography comparing their retention
times with those of commercial standards PUFA-2 (Supelco, Inc.,
Bellefonte, Pennsylvania, USA). The results are presented as per-
centage of total FA (Ristic-Medic et al. 2009). The activities of en-
zymes involved in long-chain FA syntheses were estimated as we
previously described (Tepsic et al. 2013).
Index of lipid peroxidation
The degree of lipid peroxidation in plasma was estimated by
measuring thiobarbituric acid reactive substances (TBARS) using
the method of Zeb and Ullah (2016).
Measurement of the plasma levels of cytokines TNF-
and IL-6
The cytokine concentrations in the plasma were determined
using commercial ELISA assays (Human IL-6 DUOSET ELISA devel-
opment kit and Human TNF-/TNFSF1A DUOSET ELISA develop-
ment kit; R&D Systems, Minneapolis, Minnesota, USA) according
to the manufacturer’s protocol.
Statistical analysis
The statistical analysis was performed using the statistical package
SPSS 20.0 for Windows. The results are presented as means ± SD.
The normality was tested by the Shapiro–Wilk test. The differ-
ences between orthopedic patients and the control group were
assessed with the Student t test and Mann–Whitney U test. Com-
parisons between preoperative and postoperative values in ortho-
pedic patients were performed by paired t test and Wilcoxon test
for nonnormally distributed variables. Pearson’s correlation anal-
ysis was used to study correlations between cytokines and FA. The
alpha level for significance was set to p < 0.05.
Results
Demographic characteristics of the study population are pre-
sented in Table 1. There were no differences between groups of
patients and the control group in terms of ages, gender, and os-
teoporosis.
Plasma lipids FA profile
The plasma lipid FA profiles in patients with femoral neck frac-
ture before surgery (preop) and 7 days after the surgery (postop)
and the control group are presented in Table 2. As can be seen, the
plasma FA profiles in patients, determined within 12 h after the
fracture, markedly differed from those in the control group.
Levels of palmitic acid (16:0) and total SFA as well as level of oleic
(18:1 n-9), vaccenic acids (18:1 n-7), and total MUFA were signifi-
cantly higher in patients than in the control subjects. On the other
hand, levels of -linolenic (18:3 n-6), AA, and docosatetraenoic acid
(22:4 n-6) as well as total PUFA and n-6 PUFA were significantly
lower in patients with femoral fractures than in the control
group. Further, all identified n-3 FA, including ALA, eicosapenta-
enoic acid (20:5 n-3), docosapentaenoic acid (22:5 n-3), DHA, and
total n-3 PUFA were markedly lower in the patient group when
compared with the controls (Table 2.). The n-6/n-3 PUFA ratio was
very high in all patients, unlike in the control subjects.
On the seventh day after the surgery, plasma FA profiles in
patients noticeably changed in comparison with the profiles be-
fore surgery. Levels of palmitic acid and total SFA significantly
increased, while the level of stearic acid (18:0) decreased during
this period. In addition, the level of oleic acid, which is the most
Table 1. Demographic and clinical characteristics of the study
population.
Patients (n = 20) Controls (n = 17)
Age (years) 73.4±8.2 64−86 71.5±6.7 64−79
Male (%) 20 4 (20) 23.5 4 (17)
Female (%) 80 16 (20) 76.5 13 (17)
History of osteoporosis (%) 35 7 (20) 35.3 6 (17)
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common MUFA, increased and levels of LA, total PUFA, and n-6
PUFA were significantly reduced at the end of the study. Among
n-3 PUFA, only ALA significantly decreased 7 days after surgery,
while other PUFA remained unchanged.
Estimated activity of plasma desaturase
As shown in Table 3, the estimated activity of plasma elongase
decreased, while the estimated activity of plasma 9 desaturase
significantly increased in patients with fracture during 7 days
after intervention. When compared with the control group, the
estimated activity of plasma 9 desaturase was higher, while ac-
tivities of 6 and 5 desaturases were significantly lower in the
patients.
Level of TNF-, IL-6, and TBARS
Figures 1, 2, and 3 display the levels of TNF-, IL-6, and TBARS
before and 7 days after the surgery. We found a significantly
(p < 0.05) increased level of TNF- and a significantly decreased
(p < 0.001) level of IL-6 7 days after surgery.
Table 4 shows the correlation of FA with inflammatory markers
and lipid peroxidation in this study. Our results have shown a
moderate inverse correlation of IL-6 with MUFA (r = –0.509) and a
positive correlation with DHA and n-3 PUFA (r = 0.605 and 0.490,
respectively). TNF- was inversely associated with MUFA as well
(r = –0.469) and in positive correlation with PUFA (r = 0.435) and
Table 2. Fatty acid profile in total plasma lipids in patients with frac-











16:0 30.65±2.28### 33.33±1.44*** 27.31±1.23
16:1 1.96±0.84 1.90±0.72 1.52±0.56
18:0 13.53±1.17 12.66±1.91* 13.40±1.28
18:1 n-9 15.91±1.81## 16.84±1.98* 13.83±1.35
18:1 n-7 2.24±0.55### 2.23±0.55 1.60±0.24
18:2 n-6 24.53±3.33 22.65±2.81*** 23.41±2.53
18:3 n-6 0.44±0.29### 0.42±0.25 0.92±0.24
20:3 n-6 1.93±0.88 1.91±0.67 2.29±0.50
20:4 n-6 6.47±1.43### 5.91±1.56 11.77±1.20
22:4 n-6 0.31±0.14### 0.32±0.27 0.57±0.15
18:3 n-3 0.22±0.07## 0.17±0.08* 0.45±0.20
20:5 n-3 0.26±0.18# 0.21±0.11 0.44±0.19
22:5 n-3 0.33±0.09## 0.32±0.14 0.60±0.25
22:6 n-3 1.22±0.52## 1.13±0.34 1.91±0.52
SFA 44.18±2.17### 45.99±2.35** 40.70±1.67
MUFA 20.12±2.63### 20.98±2.16 16.95±1.52
PUFA 35.17±3.71### 33.03±2.61*** 42.35±2.22
n-6 33.67±3.69### 31.20±2.51*** 38.96±2.68
n-3 1.95±0.79### 1.83±0.41 3.39±0.87
n-6/n-3 18.04±5.02### 17.92±4.39 11.65±3.93
Note: Preop, postfracture and preoperative; Postop, postoperative; SFA, satu-
rated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated
fatty acid. *p < 0.05, **p < 0.01, ***p < 0.001 compared with presurgery; #p < 0.05,
##p < 0.01, ###p < 0.001 compared with the control group.
Table 3. The estimated plasma desaturase and elongase activities in











18:0/16:0 (elongase) 0.44±0.06 0.38±0.06*** 0.48±0.06
18:1/18:0 (9 desaturase) 1.19±0.20# 1.38±0.40* 1.06±0.13
18:3 n-6/18:2 n-6 (6 desaturase) 0.02±0.01### 0.02±0.01 0.04±0.01
20:4 n-6/20:3 n-6 (5 desaturase) 3.79±1.34## 3.40±1.31 5.46±1.45
Note: Preop, postfracture and preoperative; Postop, postoperative; *p < 0.05,
***p < 0.001 compared with presurgery; #p < 0.05, ##p < 0.01, ###p < 0.001 com-
pared with control group.
Fig. 1. The plasma level of TNF- in the control and patient groups.
[Colour online.]
Fig. 2. The plasma level of IL-6 in the control and patient groups.
[Colour online.]
Fig. 3. The plasma level of TBARS in the control and patient groups.
[Colour online.]
Table 4. Correlation of fatty acids with inflammatory markers
and lipid peroxidation.
Fatty acid TNF-, r (p) IL-6, r (p) TBARS, r (p)
Preop (n = 20)
SFA −0.446 (0.043)
MUFA −0.469 (0.032) −0.509 (0.019)
PUFA +0.435 (0.043)
Postop (n = 20)
16:1 n-7 +0.462 (0.035) +0.605 (0.004) +0.524 (0.015)
18:3 n-3 +0.490 (0.024)
22:6 n-3
Total n-3
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palmitoleic acid (r = 0.462). TBARS was inversely correlated with
SFA(r = –0.446) and positively with ALA (r = 0.524).
Discussion
This study demonstrated marked differences in FA profiles be-
tween elderly patients with femoral neck fractures and age- and
sex-matched control subjects. Further alterations were found dur-
ing the followup after the surgery.
The group of patients had significantly higher levels of palmitic
acid and total SFA, which were further increased after the surgery.
Since these FA are highly atherogenic and associated with an
increased risk of cardiovascular mortality and morbidity (Stanley
et al. 2007), these changes are unfavorable. According to a clinical
case control study in a Chinese population, a diet rich in total fats
and SFA might increase the risk of hip fractures in the elderly
(Zeng et al. 2015). Although the FA status in patients before frac-
ture was unknown, further elevation of SFA may have a negative
effect on bone healing.
Further, we detected higher levels of oleic and vaccenic acid and
total MUFA in patients with femoral neck fractures than in the
control group. The literature data on the effect of dietary MUFA or
their status in plasma on bone health in animals and humans are
sparse. However, some authors suggest a positive correlation be-
tween MUFA in the diet and bone density (Orchard et al. 2010).
Martínez-Ramírez et al. (2007) reported an association between
higher dietary intake of MUFA and reduced risk of fracture in the
elderly. Thus, the herein observed increase in 9 desaturase activ-
ity that converts SFA into MUFA may have a protective role and aid
in recovery after the surgery.
PUFA may influence bone health preferably via gene expression
but also via reduction of proinflammatory cytokines (Maurin et al.
2005; Priante et al. 2002), stimulation of osteoblastic differentia-
tion by increasing insulin-like growth factor-1 and parathyroid
hormone (Shen et al. 2006), and by increased generation of nitric
oxide (Rahman et al. 2009). A few hours after fractures, patients in
our study had lower levels of n-6 gamma-linolenic acid (GLA), AA,
and docosatetraenoic acid (DTA) as well as total PUFA and n-6
PUFA compared to the control group. Seven days after the surgery,
total PUFA and n-6 PUFA further decreased and LA also decreased
in comparison to the level after the fracture. Furthermore, when
we compared FA profiles of patients with or without a history of
osteoporosis, there were no significant differences. However, al-
though approximately a third of the patients were diagnosed with
osteoporosis before the fracture, all patients were older than
64 years and thus we can assume that all of them had primary
osteoporosis.
The early physiological response to a fracture implies hypoxia
and inflammation, which induces synthesis of cytokines and spe-
cific growth factors that stimulate cell proliferation and migra-
tion into the site of the fracture (Marsell and Einhorn 2011). An
important class of mediators in these processes are prostaglan-
dins (PG), produced by osteoblasts, with the amount and the types
of synthesized PG depending on different stimuli (Blackwell et al.
2010). The most common precursor for PG synthesis is AA from
membrane phospholipids released by activity of phospholipase
A2 and then converted into PGH2 and specific prostaglandins
such as PGE2, PGD2, PGF2 prostacyclin (PGI2), and thromboxane
(Blackwell et al. 2010). PGE2 is the most abundant and most im-
portant prostaglandin in bone, which modulates both bone re-
sorption and formation depending on the amount of PGE2 (Li
et al. 2007). It has been shown that a low level of PGE2 stimulates
bone formation in animals with moderate dietary intake of n-6
PUFA (Kruger et al. 1998). A very low level of AA in patients with a
femoral neck fracture could be explained by its intensive conver-
sion into PGE2. In addition, decreased levels of GLA and dihomo-
gamma-linolenic acid (DGLA) could be due to their conversion into
AA to compensate for higher AA consumption. A reduced level of
DTA (22:4 n-6) is also a consequence of low AA level in the patient
group. Thus, decreased level of n-6 PUFA, observed immediately
after the fracture in our patients compared with the control
group, may be a result of intensive synthesis of PG. Nevertheless,
we cannot exclude the possibility of altered FA status in these
patients before the fracture. On the other hand, the patients had
a normal level of LA, which serves as a marker of a good nutri-
tional status at the time of fracture (McCarthy et al. 1991). Seven
days after the surgery, we found a decreased level of LA (18:2 n-6),
a precursor of all other n-6 PUFA, in plasma lipids. It suggests
increased conversion of LA into its products (GLA, DGLA, AA, and
DTA), but in spite of this, we found a further decrease of all n-6
PUFA probably due to a high generation of PGE2. In addition to n-6
PUFA, the level of all n-3 PUFA is severely lower in the patients
than in the control group after the fracture and even lower 7 days
after the surgery. Plasma levels of n-3 PUFA positively correlated
with the bone mineralization in both mice and humans and
higher n-3 PUFA intake reduces the fracture risk (Harris et al.
2015). It has been found that n-3 PUFA reduce PGE2 synthesis,
suppress inflammation, and promote bone repair by enhancing
production of insulin-like growth factors, which are potent
growth stimulators for bone remodeling (Weitzmann and Pacifici
2006). Additionally, n-3 PUFA have been shown to increase the absorp-
tion of dietary calcium needed for fracture healing (Weitzmann and
Pacifici 2006). The complex relationships among FA, cytokines/in-
flammation, and fracture risk and healing are displayed in Fig. 4.
Changes in cytokine levels have shown that the IL-6 level grows
quickly after the fracture but significantly declines 7 days after
the surgery. On the contrary, TNF- increased during the postop-
erative period. Level of TBARS has not changed during the 7 days
of postop period and it was lower than in the healthy people.
The inverse correlation between MUFA and markers of inflam-
mation, IL-6 and TNF-, is in line with previous studies, which
concluded that oleic acid did not promote inflammation in
healthy adults (Kalogeropoulos et al. 2010). Positive correlation of
palmitoleic acid with TNF- also aligns with previous data, which
reported that palmitoleic acid was associated with an adverse
adipokine profile and metabolic disorders (Zong et al. 2012). PUFA
also positively correlated with TNF-, and here, it should be em-
phasized that PUFA is a mix of both pro- and antiinflammatory
PUFA. However, positive correlation of DHA and n-3 PUFA with
IL-6 is in contrast with the literature data, since the antiinflam-
matory action of n-3 PUFA is well known (Vucic et al. 2015). Nev-
ertheless, studies are mostly focused on the healthy population,
while we conducted this study in patients with a high grade of
inflammation. One possible explanation is that in these condi-
tions, high production of IL-6 is conditioned by a high consump-
tion of AA, which altered the FA profile and made the relative
concentrations of DHA and n-3 PUFA relatively higher. Further
studies in patients with acute inflammation are needed to explore
the relationship between FA status and inflammatory markers.
This study provides an insight into the status of FA in plasma
lipids of patients with femoral neck fracture. Other studies mostly
focused on the relationship between intake and risk of fracture.
Although dietary intake influences FA profiles in plasma, the FA
metabolism affects the results as well; thus, it is important to
check the PUFA status in the blood of elderly people. In line with
our primary hypothesis, patients had lower n-3, n-6, and total
PUFA status than the control group. However, during the healing,
their PUFA status further decreased; that might be a consequence
of a high level of PUFA conversion into both pro- and antiinflam-
matory eicosanoids.
This study has two limitations: a relatively low number of pa-
tients and a lack of FA status of the patients before the fracture.
Thus, it has given significant inputs for future research: since
the time from the fracture to blood drawn was mostly short, it is
likely that elderly patients with femoral neck fractures had al-
tered FA status in the plasma before the fracture, in particular low
64 Can. J. Physiol. Pharmacol. Vol. 98, 2020
























































n-3 PUFA, which makes them more susceptible for fractures. Iden-
tification and PUFA supplementation in these people could help
in fracture prevention. Further, nutritional intervention after the
fracture may improve the healing process. Future studies should
address the potential benefits of high PUFA intake in bone frac-
tures.
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